To further investigate the therapeutic potential of GPNMB in obesity-related metabolic disorders, beneficial effects of GPNMB-ECD supplementation in metabolic homeostasis in WT obese mice need to be explored in the future. This evidence concerns the gene GPNMB and obesity due to melanocortin 4 receptor deficiency.